Showing results (91-100 of 271) with videos related to
Sort By:
Pageof 28
Current Opinion in Cardiology|June 8, 2015
Erectile dysfunction and coronary heart diseaseNiki Katsiki, Anthony S Wierzbicki, Dimitri P MikhailidisCurrent Vascular Pharmacology|July 16, 2009
Future challenges for microsomal transport protein inhibitorsAnthony S Wierzbicki, Tim Hardman, William T PrinceCurrent Cardiology Reports|March 23, 2016
Familial Hypercholesterolaemia in the Era of Genetic TestingD P Hughes, A Viljoen, A S WierzbickiJournal of Cardiovascular Risk|October 24, 2002
Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetesTimothy M Reynolds, Patrick Twomey, Anthony S WierzbickiInternational Journal of Clinical Practice|February 21, 2012
New lipid-lowering drugs: an updateA S Wierzbicki, T C Hardman, A ViljoenCurrent Opinion in Cardiology|April 24, 2010
Aortic stenosis and lipids: does intervention work?Anthony S Wierzbicki, Adie Viljoen, John B ChambersExpert Opinion on Investigational Drugs|April 13, 2012
Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemiaAnthony S Wierzbicki, Timothy C Hardman, Adie ViljoenAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Drug treatment of combined hyperlipidemiaA S Wierzbicki, D P Mikhailidis, R WrayCurrent Opinion in Cardiology|April 18, 2013
Epicardial fat and vascular risk: a narrative reviewNiki Katsiki, Dimitri P Mikhailidis, Anthony S WierzbickiCurrent Opinion in Endocrinology, Diabetes, and Obesity|December 26, 2021
Lipidomics in diabetesEun Ji Kim, Radha Ramachandran, Anthony S WierzbickiPageof 28